rs2671422
Positions:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_002460.4(IRF4):c.638-53G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.152 in 1,345,942 control chromosomes in the GnomAD database, including 22,107 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.21 ( 4668 hom., cov: 33)
Exomes 𝑓: 0.14 ( 17439 hom. )
Consequence
IRF4
NM_002460.4 intron
NM_002460.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -2.28
Genes affected
IRF4 (HGNC:6119): (interferon regulatory factor 4) The protein encoded by this gene belongs to the IRF (interferon regulatory factor) family of transcription factors, characterized by an unique tryptophan pentad repeat DNA-binding domain. The IRFs are important in the regulation of interferons in response to infection by virus, and in the regulation of interferon-inducible genes. This family member is lymphocyte specific and negatively regulates Toll-like-receptor (TLR) signaling that is central to the activation of innate and adaptive immune systems. A chromosomal translocation involving this gene and the IgH locus, t(6;14)(p25;q32), may be a cause of multiple myeloma. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Aug 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant 6-398775-G-A is Benign according to our data. Variant chr6-398775-G-A is described in ClinVar as [Benign]. Clinvar id is 1273865.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.501 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
IRF4 | NM_002460.4 | c.638-53G>A | intron_variant | ENST00000380956.9 | NP_002451.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
IRF4 | ENST00000380956.9 | c.638-53G>A | intron_variant | 1 | NM_002460.4 | ENSP00000370343 | P4 | |||
IRF4 | ENST00000696871.1 | c.635-53G>A | intron_variant | ENSP00000512940 | A1 | |||||
IRF4 | ENST00000696873.1 | c.203-53G>A | intron_variant | ENSP00000512942 | ||||||
IRF4 | ENST00000493114.2 | c.635-53G>A | intron_variant, NMD_transcript_variant | 5 | ENSP00000436094 |
Frequencies
GnomAD3 genomes AF: 0.213 AC: 32363AN: 152046Hom.: 4631 Cov.: 33
GnomAD3 genomes
AF:
AC:
32363
AN:
152046
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.145 AC: 172771AN: 1193778Hom.: 17439 AF XY: 0.146 AC XY: 87451AN XY: 597336
GnomAD4 exome
AF:
AC:
172771
AN:
1193778
Hom.:
AF XY:
AC XY:
87451
AN XY:
597336
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.213 AC: 32467AN: 152164Hom.: 4668 Cov.: 33 AF XY: 0.217 AC XY: 16149AN XY: 74402
GnomAD4 genome
AF:
AC:
32467
AN:
152164
Hom.:
Cov.:
33
AF XY:
AC XY:
16149
AN XY:
74402
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1410
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan | Jan 24, 2024 | This variant is classified as Benign based on local population frequency. This variant was detected in 51% of patients studied by a panel of primary immunodeficiencies. Number of patients: 48. Only high quality variants are reported. - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | Nov 12, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at